ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Metabolic complications"

  • 2021 American Transplant Congress

    Corticosteroid Reintroduction in Urban Simultaneous Kidney-pancreas Transplant Recipients Following an Early Corticosteroid Withdrawal Protocol

    D. Pierce, P. West-Thielke, M. Campara, I. Tang, M. Spaggiari, I. Tzvetanov, E. Benedetti, A. Lichvar

    University of Illinois at Chicago, Chicago, IL

    *Purpose: Approximately 30% of patients who undergo simultaneous kidney-pancreas (SKP) transplant are maintained on dual therapy with tacrolimus and mycophenolate. Long-term implications of steroid reintroduction…
  • 2021 American Transplant Congress

    Evaluation of Safety and Efficacy of PCSK9 Inhibitors in Solid Organ Transplant Recipients: Experience at a Large Multi-organ Transplant Center

    A. Ucci1, M. Norris2, J. Trofe-Clark2, T. Fallah2, M. Meck1, R. Samudralwar1, M. V. Genuardi3

    1Hospital of Univ of Pennsylvania, Philadelphia, PA, 2Penn Transplant Institute, Hospital of Univ of Pennsylvania, Philadelphia, PA, 3Cardiovascular Medicine Div, Hospital of Univ of Pennsylvania, Philadelphia, PA

    *Purpose: The aim of the study was to characterize the efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in solid organ transplant…
  • 2021 American Transplant Congress

    Insulin Secretion and Insulin Resistance Trajectories Over 1 Year After Kidney Transplantation: A Multicenter Prospective Cohort Study

    B. Jun Bae, C. Oh

    Department of Surgery, Ajou University Medical School, Suwon, Korea, Republic of

    *Purpose: We investigated the changing patterns of insulin secretion and resistance and risk factors contributing to the development of post-transplant diabetes mellitus (PTDM) in kidney…
  • 2021 American Transplant Congress

    Neutrophil Extracellular Trap-induced Thrombotic Microangiopathy in Steatotic Mouse Recipients Impacts Liver Transplant Outcomes

    H. Hirao, H. Kojima, K. Kadono, K. J. Dery, D. G. Farmer, F. M. Kaldas, J. W. Kupiec-Weglinski

    UCLA Medical Center, Los Angeles, CA

    *Purpose: Nonalcoholic steatohepatitis (NASH) is an emerging global epidemic projected to become the leading indication for liver transplantation (LT). Although recent studies focus on the…
  • 2021 American Transplant Congress

    An Unexpected Case of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Overlooked Pretransplant, but Then Diagnosed Early After Kidney Transplant with a Negative Patient Outcome: A Case Report

    W. Hoffman, M. Waybill, H. Yang, D. Ladie, M. Singh

    UPMC Pinnacle Transplant, Harrisburg, PA

    *Purpose: ATTR-CM is underrecognized and commonly overlooked and undiagnosed. When found it is often a late diagnosis in patients with severe left ventricular hypertrophy (LVH)…
  • 2021 American Transplant Congress

    Changes in Body Mass Index Before and After Kidney Transplant

    M. Laub1, S. Finder2, P. Harikrishnan1, M. Simon3, I. Gani1, M. Saeed1, R. Kapoor1

    1Augusta University Medical Center, Augusta, GA, 2Vanderbilt University Medical Center, Nashville, TN, 3Brandon Wilde, Augusta, GA

    *Purpose: Describe changes in body mass index (BMI) before and after kidney transplant and determine the association between BMI and graft loss or mortality.*Methods: Single…
  • 2021 American Transplant Congress

    Sodium Zirconium Cyclosilicate Use in Kidney Transplant Recipients

    K. J. Swanson, F. Aziz, S. Parajuli, M. Mohamed, D. A. Mandelbrot, A. Djamali, N. Garg

    University of Wisconsin-Madison, Madison, WI

    *Purpose: Hyperkalemia is a common problem experienced by kidney transplant recipients (KTR)s. New strategies to treat hyperkalemia are now available. KTRs often require medications that…
  • 2021 American Transplant Congress

    Dietary Intake of Calories and Protein in the Acute Phase Following Kidney Transplant: Opportunities for Improvement

    L. Teigen1, G. Onyeaghala1, Y. Doronin2, B. Guo1, B. Wu1, J. Abrahante1, D. Schladt1, W. Guan1, C. Staley1, M. Al-Kofahi1, S. Riad1, A. Matas1, R. Remmel1, W. Oetting1, C. Dorr1, P. Jacobson1, A. Israni1

    1University of Minnesota, Minneapolis, MN, 2Hennepin Healthcare Research Institute, Minneapolis, MN

    *Purpose: Nutritional therapy post kidney transplant includes both an acute (1-1.5 months post-transplant) and a chronic phase. To date, most of the available literature has…
  • 2020 American Transplant Congress

    GLP1-RAs, SGLT2i Are Underutilized in Kidney Transplant Recipients with Diabetes Mellitus and Obesity

    M. Stumpf, S. A. Dar, S. Rao, A. Doyle

    University of Virginia, Charlottesville, VA

    *Purpose: There is little research describing differences in use of antidiabetic medications amongst obese, diabetic patients with or without a history of kidney transplant. More…
  • 2020 American Transplant Congress

    Characterization of Gut Microbiome in Liver Transplant Recipients with Non-Alcoholic Steatohepatitis

    S. Sataphaty1, P. Banerjee2, J. Pierre3, R. Heda3, S. Dutta3, D. D. Higgins4, V. Mas5, S. Khan6, V. Mupparaju3, S. R. Nair7, J. D. Eason8, D. Kleiner9, D. Maluf10

    1Department of Surgery, Division of Hepatology and Sandra Atlas Bass Center for Liver Diseases, Northwell Health, NYC, NY, 2School of Public Health, University of Memphis, Memphis, TN, 3University of Tennessee Health Science Center, Memphis, TN, 4University of Memphis, Memphis, TN, 5James D Eason Transplant Institute, Memphis, TN, 6Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NYC, NY, 7Department of Surgery, James D Eason Transplant Institute, Memphis, TN, 8Department of Surgery, James D Eason Transplant Institute, NYC, TN, 9Laboratory of Pathology/National Cancer Institute, Bethesda, WA, 10Department of Surgery_ University of Tennessee, James D Eason Transplant Institute, NYC, TN

    *Purpose: Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH) is a growing problem globally and recurs even after liver transplant (LT).…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 11
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences